Study: NCT02817633

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-022
Description: TSR-022 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-042
Description: TSR-042 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSR-033
Description: TSR-033 will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin will be administered.